Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
PREDICTORS OF THYROID-TUMOR AGGRESSIVENESS
Autore:
CLARK OH;
Indirizzi:
UNIV CALIF SAN FRANCISCO,MT ZION MED CTR,DEPT SURG,SCH MED,1600 DIVISADERO ST SAN FRANCISCO CA 94115 UNIV CALIF SAN FRANCISCO,MT ZION MED CTR SAN FRANCISCO CA 94120
Titolo Testata:
Western journal of medicine
fascicolo: 3, volume: 165, anno: 1996,
pagine: 131 - 138
SICI:
0093-0415(1996)165:3<131:POTA>2.0.ZU;2-T
Fonte:
ISI
Lingua:
ENG
Soggetto:
PROGNOSTIC SCORING SYSTEM; PAPILLARY CARCINOMA; PULMONARY METASTASES; P53 MUTATIONS; DNA CONTENT; FOLLOW-UP; CANCER; ONCOGENE; THERAPY; DIAGNOSIS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
76
Recensione:
Indirizzi per estratti:
Citazione:
O.H. Clark, "PREDICTORS OF THYROID-TUMOR AGGRESSIVENESS", Western journal of medicine, 165(3), 1996, pp. 131-138

Abstract

Thyroid cancers are classified as papillary, follicular (including Hurthle cell), medullary, and anaplastic. Papillary cancers account for about 82% of all thyroid cancers, follicular about 8%, medullary about6%, Hurthle cell 3%, and anaplastic 1%. The prognosis of patients with papillary thyroid cancer is usually favorable, whereas most patientswith anaplastic cancer die within 6 months. The behavior of papillarythyroid cancer can be predicted by patient age, sex, tumor size, local invasion, angioinvasion, lymph node metastases, distant metastases, as well as tumor differentiation and ability to take up radioactive iodine. Thus, older male patients with larger or invasive tumors, with angioinvasion, lymph node or distant metastases, and with tumors that do not take up radioactive iodine or cannot be completely surgically resected have a worse prognosis. Anaploid tumors, tumors with a low adenylate cyclase response to thyroid-stimulating hormone tumors, tumors that are ras- and gsp-positive, and tumors that are p21-positive and p53-positive also appear to behave in a more aggressive manner. In contrast, lymphocytic thyroiditis associated with papillary thyroid cancer predicts fewer recurrences and an improved survival. The treatment of patients with papillary thyroid cancer is controversial primarily because most patients do well with relatively minimal therapy, and there are no prospective studies concerning the merits of various treatments. Much of the controversy relates to the safety of thyroidectomy versusother procedures and, to a lesser extent, when to do a central or modified radical neck dissection. The rate of recurrence is lower, and the death rate may also be lower when patients are treated initially by total thyroidectomy. The rationale for total thyroidectomy is that it enables one to use radioactive iodine to detect and treat local and distant metastases, and it makes serum thyroglobulin determination more sensitive for detecting persistent disease. Total thyroidectomy shouldbe associated with a permanent complication rate of less than 2%. Thyroid-stimulating hormone suppression therapy is recommended by most experts for patients with differentiated thyroid cancer and supported bymost clinical and laboratory studies. Central and lateral node selection is recommended for patients with palpable lymphadenopathy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/07/20 alle ore 23:56:08